Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-31 @ 2:14 PM
Study NCT ID:
NCT06582628
Status:
RECRUITING
Last Update Posted:
2024-12-02
First Post:
2024-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Sponsor:
Fundacion Oncosur